A new study published in the Journal of Perinatology, suggests that blood tests can be used to predict the risk of preterm births among pregnant women with and without preeclampsia.
The researchers found that screening for specific biomarkers along with understanding certain demographic information about the patient could identify the risk of most of the women in the study during their second trimester of pregnancy.
Senior author Kelli Ryckman, associate professor of epidemiology at the University of Iowa College of Public Health, says that knowing which women are in the high risk group would allow providers to suggest additional monitoring and even offer an opportunity for intervention.
“For example, our test identified about 95 percent of women who had a preterm birth with preeclampsia before 32 weeks,” Ryckman says. “These women could be offered low-dose aspirin as a way to help lower their risk for preeclampsia.”
The test, developed and studied in 400 women during their second trimester, screened for 25 biomarkers or substances in the blood that were signs of inflammation and immune system activation, as well as certain protein levels, indicative of a possible preterm birth risk.
While the results of the study are encouraging, Ryckman notes that the test is still in very early stages of development, and more research is needed to determine its accuracy and safety.
Additional authors of the study are Laura L. Jelliffe-Pawlowski, Larry Rand, and Mary E. Norton, University of California San Francisco School of Medicine; Bruce Bedell and Jeffrey C. Murray, University of Iowa Carver College of Medicine; Rebecca J. Baer and Scott P. Oltman, University of California San Diego; and Gary M. Shaw and David K. Stevenson, Stanford University School of Medicine.
Funding for the study was provided by the Bill & Melinda Gates Foundation, NIH/NHLBI, the March of Dimes Prematurity Center at Stanford University School of Medicine, the Stanford Child Health Research Institute at Stanford University School of Medicine, the Stanford Clinical and Translational Science Award CTSA to Spectrum, the March of Dimes Prematurity Center—Ohio Collaborative, March of Dimes, and the California Preterm Birth Initiative at the University of California San Francisco Benioff Children’s Hospital.
Related Media Coverage
A new study from the University of Iowa finds that children with autism spectrum disorder (ASD) are more than twice as likely to suffer from a food allergy than children who do not have ASD.
Wei Bao, assistant professor of epidemiology at the UI College of Public Health and the study’s corresponding author, says the finding adds to a growing body of research that suggests immunological dysfunction as a possible risk factor for the development of ASD.
“It is possible that the immunologic disruptions may have processes beginning early in life, which then influence brain development and social functioning, leading to the development of ASD,” says Bao.
The study analyzed the health information of nearly 200,000 children gathered by the U.S. National Health Interview Survey (NHIS), an annual survey of American households conducted by the U.S. Centers for Disease Control and Prevention. The children were between the ages of 3 and 17 and the data were gathered between 1997 and 2016.
The study found that 11.25 percent of children reportedly diagnosed with ASD have a food allergy, significantly higher than the 4.25 percent of children who are not diagnosed with ASD and have a food allergy.
Bao says his study could not determine the causality of this relationship given its observational nature. But previous studies have suggested possible links—increased production of antibodies, immune system overreactions causing impaired brain function, neurodevelopmental abnormalities, and alterations in the gut biome. He says those connections warrant further investigation.
“We don’t know which comes first, food allergy or ASD,” says Bao, adding that another longitudinal follow-up study of children since birth would be needed to establish temporality.
He says previous studies on the association of allergic conditions with ASD have focused mainly on respiratory allergy and skin allergy, and those studies have yielded inconsistent and inconclusive results. The new study found 18.73 percent of children with ASD suffered from respiratory allergies, whereas only 12.08 percent of children without ASD had such allergies, and 16.81 percent of children with ASD had skin allergies, well above the 9.84 percent of children without ASD.
“This indicates there could be a shared mechanism linking different types of allergic conditions to ASD,” says Bao.
Bao says the study is limited in that the NHIS depends on respondents to voluntarily self-report health conditions, so the number of children with ASD or allergies may be misreported by those taking the survey. But he says the large number of respondents and ethnic and gender cross-representation of the survey are major strengths.
The study, “Association of Food Allergy and Other Allergic Conditions with Autism Spectrum Disorder in Children,” was published online in the June 8 issue of JAMA Network Open. The first author is Guifeng Xu, PhD candidate in the UI College of Public Health and graduate research assistant in the UI Roy J. and Lucille A. Carver College of Medicine. Additional co-authors include Linda G. Snetselaar, professor of epidemiology in the UI College of Public Health; Jin Jing, professor of maternal and child health at the Sun Yat-Sen University in China; Buyun Liu, postdoctoral researcher in the UI College of Public Health; and Lane Strathearn, professor of pediatrics in the Carver College of Medicine.
This story originally appeared in Iowa Now
Additional Media Coverage
American Journal of Managed Care
For the past several years, health care reform efforts have focused on reducing preventable hospital readmissions. However, a new study co-authored by Brad Wright, assistant professor of health management and policy at the University of Iowa, suggests that when the rising number of patients hospitalized for outpatient observation is factored in, declines in readmissions disappear.
According to the study, “Commercial payers and state Medicaid agencies have increasingly [required] hospitals to report data on readmissions and…occasionally [link] reimbursement and purchasing agreements to performance. Consequently, although experts continue to challenge the usefulness of readmission rates for assessing quality of care, the rates are now broadly accepted as a measure of hospital quality by payers and policymakers.”
right and lead author Amber K. Sabbatini, assistant professor of emergency medicine at the University of Washington, studied data for the period between 2007 and 2015 from the Truven Health Analytics MarketScan Commercial Claims and Encounters Database. They examined claims for emergency department visits that resulted in observation stays and followed these patients to measure 30-day readmission trends. These data were used to compare observation stay readmission trends to inpatient stay readmission trends.
Sabbatini and Wright found that while inpatient readmissions decreased from 17.8% to 15.5% during the study period, 30-day readmissions after an outpatient observation stay increased from 10.9% to 14.8%. The data also showed that repeat observation stays increased from 3.6% to 6.9%.
While some may be tempted to see these results as evidence of hospitals using observation stays to game readmissions measures and avoid the penalties associated with them, Sabbatini and Wright stress that this is not the case. Rather, the study concludes that observation stays should be considered part of 30-day readmission quality measurements in order to ensure that hospitals focus the same amount of resources on preventing readmissions in these patients.
“All patients with an acute condition require timely and coordinated care,” the authors wrote. “Moreover, there is no reason to think that a repeat observation stay is any less preventable or less reflective of the quality of care transitions than an inpatient readmission. Although repeat observation stays cost payers less than inpatient readmissions, they still represent excess costs for the health care system and are meaningful for patients.”
Additional Media Coverage